Minimal infectious dose and dynamics of Babesia microti parasitemia in a murine model

Transfusion

Volumn 58, Issue 12, 2018, Pages 2903-2910

  Bakkour, Sonia ^a,b   Chafets, Daniel M ^a   Wen, Li ^a   Muench, Marcus O ^a,b   Telford, Sam R ^c   Erwin, James L ^d   Levin, Andrew E ^d   Self, Deanna ^e   Brès, Vanessa ^e   Linnen, Jeffrey M ^e   Lee, Tzong Hae ^a   Busch, Michael P ^a,b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TUFTS UNIVERSITY   (United States)

^d IMMUNETICS INC   (United States)

^e Grifols Diagnostic Solutions Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA; RNA; PROTOZOAL DNA; PROTOZOAL RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BABESIA MICROTI; CONTROLLED STUDY; DBA 2 MOUSE; ENZYME IMMUNOASSAY; ERYTHROCYTE; FEMALE; INFECTIOUS DOSE; KINETICS; MALE; MINIMAL INFECTIOUS DOSE; MOUSE; MOUSE MODEL; NOD SCID GAMMA MOUSE; NONHUMAN; PARASITEMIA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; ANIMAL; BLOOD; DISEASE MODEL; METABOLISM; NONOBESE DIABETIC MOUSE; PARASITOLOGY; PIROPLASMOSIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BABESIA MICROTI; BABESIOSIS; DISEASE MODELS, ANIMAL; DNA, PROTOZOAN; ERYTHROCYTES; FEMALE; MICE; MICE, INBRED NOD; PARASITEMIA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, PROTOZOAN;

EID: 85053906333     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14889     Document Type: Article

References (28)

1. Herwaldt BL, Linden JV, Bosserman E, et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011;155:509-19.
2. Moritz ED, Winton CS, Tonnetti L, et al. Screening for Babesia microti in the U.S. blood supply. N Engl J Med 2016;375:2236-45.
3. Gubernot DM, Nakhasi HL, Mied PA, et al. Transfusion-transmitted babesiosis in the United States: summary of a workshop. Transfusion 2009;49:2759-71.
4. Blood Products Advisory Committee Meeting Summary Minutes [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2015 [cited 2017 Nov 28]. Available from: https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/ucm457554.htm
5. Meissner EG, McGillicuddy JW, Squires J, et al. Across state lines: fulminant Babesia microti infection in a liver transplant recipient. Transpl Infect Dis 2017;19:e12741.
6. LeBel DP, Moritz ED, O'Brien JJ, et al. Cases of transfusion-transmitted babesiosis occurring in nonendemic areas: a diagnostic dilemma. Transfusion 2017;57:2348-54.
7. Brennan MB, Herwaldt BL, Kazmierczak JJ, et al. Transmission of Babesia microti parasites by solid organ transplantation. Emerg Infect Dis 2016;22:1869-76.
8. Levin AE, Williamson PC, Bloch EM, et al. Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay. Transfusion 2016;56:1866-74.
9. Drew VJ, Barro L, Seghatchian J, et al. Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries. Blood Transfus 2017;15:512-21.
10. Tonnetti L, Thorp AM, Reddy HL, et al. Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood. Transfusion 2013;53:860-7.
11. Tonnetti L, Laughhunn A, Thorp AM, et al. Inactivation of Babesia microti in red blood cells and platelet concentrates. Transfusion 2017;57:2404-12.
12. Vannier E, Borggraefe I, Telford SR, et al. Age-associated decline in resistance to Babesia microti is genetically determined. J Infect Dis 2004;189:1721-8.
13. Jackman RP, Utter GH, Muench MO, et al. Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion 2012;52:2533-50.
14. Bloch EM, Lee TH, Krause PJ, et al. Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection. Transfusion 2013;53:2299-306.
15. Levin AE, Williamson PC, Erwin JL, et al. Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion 2014;54:2237-44.
16. Lemieux JE, Tran AD, Freimark L, et al. A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse. Nat Microbiol 2016;1:16079.
17. Etkind P, Piesman J, Ruebush TK, et al. Methods for detecting Babesia microti infection in wild rodents. J Parasitol 1980;66:107-10.
18. Fang DC, McCullough J. Transfusion-transmitted Babesia microti. Transfus Med Rev 2016;30:132-8.
19. Lustig Y, Mendelson E, Paran N, et al. Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016. Euro Surveill 2016;21:7-10.
20. Mansuy JM, Mengelle C, Pasquier C, et al. Zika virus infection and prolonged viremia in whole-blood specimens. Emerg Infect Dis 2017;23:863-5.
21. Yek C, Massanella M, Peling T, et al. Evaluation of the Aptima HIV-1 Quant Dx assay for HIV-1 RNA quantitation in different biological specimen types. J Clin Microbiol 2017;55:2544-53.
22. Hanron AE, Billman ZP, Seilie AM, et al. Detection of Babesia microti parasites by highly sensitive 18S rRNA reverse transcription PCR. Diagn Microbiol Infect Dis 2017;87:226-8.
23. Gumber S, Nascimento FS, Rogers KA, et al. Experimental transfusion-induced Babesia microti infection: dynamics of parasitemia and immune responses in a rhesus macaque model. Transfusion 2016;56:1508-19.
24. Leiby DA, Johnson ST, Won KY, et al. A longitudinal study of Babesia microti infection in seropositive blood donors. Transfusion 2014;54:2217-25.
25. Bloch EM, Levin AE, Williamson PC, et al. A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors. Transfusion 2016;56:1875-82.
26. Moritz ED, Tonnetti L, Hewins ME, et al. Description of 15 DNA-positive and antibody-negative “window-period” blood donations identified during prospective screening for Babesia microti. Transfusion 2017;57:1781-6.
27. Ruebush MJ, Hanson WL. Susceptibility of five strains of mice to Babesia microti of human origin. J Parasitol 1979;65:430-3.
28. Skariah S, Arnaboldi P, Dattwyler RJ, et al. Elimination of Babesia microti is dependent on intraerythrocytic killing and CD4+ T cells. J Immunol 2017;199:633-42.